Kiadis Pharma Continues to Provide Rhitol to Participating Physicians During Completion of Current Clinical Study
Amsterdam, November 19 (ots/PRNewswire) - Kiadis Pharma announced today that it has agreed to provide Rhitol during a limited period of time to requesting physicians participating in the ongoing phase I/II trial. The Rhitol phase I/II trial is closed for enrolment to treat new patients and is expected to complete ...
plus